Dermatology Times Staff

The FDA has reversed a long-standing guidance stating that sponsors of clinical trials for atopic dermatitis (AD) in pediatrics need not start the trial in adults first. Here's what you need to know.

Asana BioSciences announced that the U.S. Food and Drug Administration granted fast-track designation for the investigational ASN002, an oral treatment for moderate-to-severe atopic dermatitis. Learn more in this article.

Sandoz, a division of Novartis, announced that the U.S. Food and Drug Administration approved its biosimilar, adalimumabadaz (Hyrimoz, Novartis AG). 

The cost of clinical trials to get a dermatology drug to market may cost as much as $25 million, which is slightly above a median of $19 million, according to the latest research.

The American Academy of Dermatology annual meeting will be held from March 1-5 in Washington, D.C.

The National Psoriasis Foundation and the National Eczema Association have awarded Procter & Gamble’s Tide Free and Gentle Liquid Laundry Detergent and Tide PODS Free and Gentle Laundry Detergent a “Seal of Recognition” and “Seal of Acceptance” for people with eczema or sensitive skin.

Image IQ: An 8-year-old girl with a sore throat, deep red tongue, fever and a petechial rash. What’s your diagnosis?

Before 2018 comes to a close, we wanted to say thank you to our readers from everyone here at Dermatology Times. As a thank you, we have compiled a list of the topics and issues you found most compelling throughout the year. Enjoy this slideshow - and see you in 2019!

We've gathered our latest and greatest articles on excessive sweating so you can sit back and relax over the holiday. From a new topical to Botox to treatments yet to come, our slideshow contains all you need to know about novel hyperhidrosis treatments.

The Orlando Dermatology Aesthetic & Clinical Conference (ODAC), formerly known as Orlando Derm, is scheduled for January 18-21 at the JW Marriott in Orlando.

Crown Laboratories has acquired Bellus Medical, allowing the firm to secure a variety of noninvasive aesthetic products, according to a company news release.

Almirall has closed on an agreement to acquire Allergan’s medical dermatology unit in the United States for $550 million.

The U.S. Food and Drug Administration has approved clearance for a new acne treatment that selectively targets sebaceous glands, according to a news release.

Proscia Inc., a digital technology company specializing in the development of artificial intelligence applications and software for digital pathology, recently secured $8.3 million in an initial round of financing.

We've gathered eight of our most interesting Legal Eagle articles from 2018, in which Dr. David J. Goldberg helps navigate some of the most complicated legal questions facing dermatologists today.

Image IQ:  A man presents to his doctor with hand numbness, pain, skin tightness and raised scars. What’s your diagnosis?

Investigators from the Health Hazard Evaluation Program of the Centers for Disease Control and Prevention recently issued these safety recommendations for tattoo removal.

Zoe Diana Draelos, M.D., clinical and research dermatologist, offers guidance on several cosmetic issues. View our slideshow of the top 8 Cosmetic Conundrums from 2018.

Image IQ: A 52-year-old man undergoing chemotherapy experiences erythematous lesions on his palms and soles five days after treatment. What’s your diagnosis?

The Food and Drug Administration (FDA) approved sarecycline (Seysara, Almirall, S.A.) in October for the treatment of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older, according to a company news release.

Victor Desmond Mandel, M.D. and colleagues describe a reconstruction strategy for chronic infected neoplastic ulcers of the lower extremities using a dermal matrix and a unique postoperative dressing protocol.

Image IQ: A 55-year-old woman with a history of inflammatory bowel disease reported a very painful, deep pustule on her leg that may rupture. What’s your diagnosis?

Widespread rashes, red perpendicular lines and mysterious deep pustules are among the skin manifestations we feature in this collection of image IQs.

The American Academy of Dermatology has updated its guidelines for the care and management of primary cutaneous melanoma. The guidelines, which were released this week, cover the treatment of primary cutaneous melanoma for all age groups.

Image IQ:  A 43-year-old man with a symmetrical palpable purpura rash on his legs. What’s your diagnosis?

A 10-year-old girl is experiencing hair loss with no signs of lesions or scarring on her scalp. What’s your diagnosis?